2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Top Cited Papers
- 1 October 2014
- journal article
- practice guideline
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 30 (10), 1114-1130
- https://doi.org/10.1016/j.cjca.2014.08.001
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 scoreHeart Rhythm, 2013
- Association of atrial fibrillation with mortality and disability after ischemic strokeNeurology, 2013
- Excessive Supraventricular Ectopic Activity Is Indicative of Paroxysmal Atrial Fibrillation in Patients with Cerebral IschemiaPLOS ONE, 2013
- Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysisJournal of the American Heart Association, 2013
- Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral AnticoagulationCanadian Journal of Cardiology, 2013
- Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trialThe Lancet, 2012
- Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial FibrillationJournal of the American College of Cardiology, 2012
- 2010 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Training Standards and Maintenance of Competency in Adult Clinical Cardiac ElectrophysiologyCanadian Journal of Cardiology, 2011
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitorBritish Journal of Clinical Pharmacology, 2010